1 results match your criteria: "Tallaght Hospital and School of Medicine Trinity College Dublin Dublin Ireland.[Affiliation]"
Positive relationship between infliximab and adalimumab trough levels at completion of induction therapy with clinical response rates, at a tertiary referral center.
JGH Open
September 2017
Department of Gastroenterology, Tallaght Hospital and School of Medicine Trinity College Dublin Dublin Ireland.
Background And Aim: Anti-tumor necrosis factor alpha (TNFα) therapies have improved outcomes for patients with inflammatory bowel disease. The aim of this study was to explore the relationship between infliximab (IFX) and adalimumab (ADL) trough and antibody levels with clinical response rates at the end of induction.
Methods: This was a prospective, single-center study.